<--- Back to Details
First PageDocument Content
Food and Drug Administration / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology / Drug safety / Investigational New Drug / New Drug Application / Clinical trial / Expanded access / Clinical research / Research / Health
Food and Drug Administration
Pharmaceutical industry
Pharmaceutical sciences
Pharmacology
Drug safety
Investigational New Drug
New Drug Application
Clinical trial
Expanded access
Clinical research
Research
Health

How to put together the application

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 913,55 KB

Share Document on Facebook

Similar Documents

Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmace

DocID: 1uvYN - View Document

Guidance for Industry Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic,

DocID: 1sDEk - View Document

Medical research / Health / Food and Drug Administration / Pharmaceutical industry / Drug safety / Clinical pharmacology / Expanded access / Clinical trial / Investigational New Drug / Informed consent / New drug application / Health Insurance Portability and Accountability Act

Emergency Use: means the use of a test article on a human subject in a life-threatening situation in

DocID: 1riMu - View Document

Health / Pharmaceutical industry / Food and Drug Administration / Pharmacology / Pharmaceuticals policy / Food law / Food safety / Good manufacturing practice / Compounding / Title 21 of the Code of Federal Regulations / Federal Food /  Drug /  and Cosmetic Act / Investigational New Drug

Microsoft Word - 7494fnl.doc

DocID: 1qYy2 - View Document

Food and Drug Administration / Health / Medical research / Pharmaceutical industry / Drug safety / Clinical research / Investigational New Drug / Treatment IND / Center for Drug Evaluation and Research / Drug development / Expanded access / New drug application

Microsoft Worddoc

DocID: 1qVAJ - View Document